These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 30995854)

  • 1. Hepatic Injury Induced by a Single Dose of Nivolumab - a Case Report and Literature Review.
    Kopecký J; Kubecek O; Geryk T; Podhola M; Ziaran M; Priester P; Hanisova M; Borilova S
    Klin Onkol; 2019; 32(2):133-138. PubMed ID: 30995854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dramatic effect of nivolumab against melanoma and immune-related liver toxicity: A detailed histopathological and immunohistochemical analysis of nivolumab-induced liver toxicity.
    Namiki T; Nojima K; Chikazawa S; Iwamoto Y; Otsuki Y; Albusani H; Miura K; Kiyokawa Y; Asakage T; Yokozeki H
    J Dermatol; 2019 May; 46(5):e182-e183. PubMed ID: 30474878
    [No Abstract]   [Full Text] [Related]  

  • 3. Erythema Nodosum as the Initial Presentation of Nivolumab-Induced Sarcoidosis-Like Reaction.
    Laroche A; Alarcon Chinchilla E; Bourgeault E; Doré MA
    J Cutan Med Surg; 2018; 22(6):627-629. PubMed ID: 29772919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute interstitial nephritis after sequential ipilumumab - nivolumab therapy of metastatic melanoma.
    Bottlaender L; Breton AL; de Laforcade L; Dijoud F; Thomas L; Dalle S
    J Immunother Cancer; 2017 Jul; 5(1):57. PubMed ID: 28716106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple nivolumab-induced CNS demyelination with spontaneous resolution in an asymptomatic metastatic melanoma patient.
    Pillonel V; Dunet V; Hottinger AF; Berthod G; Schiappacasse L; Peters S; Michielin O; Aedo-Lopez V
    J Immunother Cancer; 2019 Dec; 7(1):336. PubMed ID: 31791418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bullous Pemphigoid-like Skin Lesions and Overt Eosinophilia in a Patient With Melanoma Treated With Nivolumab: Case Report and Review of the Literature.
    Anastasopoulou A; Papaxoinis G; Diamantopoulos P; Christofidou E; Benopoulou O; Stratigos A; Gogas H
    J Immunother; 2018 Apr; 41(3):164-167. PubMed ID: 29309291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nivolumab induced encephalopathy in a man with metastatic renal cell cancer: a case report.
    Kopecký J; Kubeček O; Geryk T; Slováčková B; Hoffmann P; Žiaran M; Priester P
    J Med Case Rep; 2018 Sep; 12(1):262. PubMed ID: 30217214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dermatomyositis in a patient undergoing nivolumab therapy for metastatic melanoma: a case report and review of the literature.
    Kosche C; Stout M; Sosman J; Lukas RV; Choi JN
    Melanoma Res; 2020 Jun; 30(3):313-316. PubMed ID: 31567590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymyalgia rheumatica in a melanoma patient 11 months after completion of immunotherapy with nivolumab.
    Lobo Y; Good P; Murphy F
    Cancer Rep (Hoboken); 2020 Jun; 3(3):e1244. PubMed ID: 32671986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late-onset isolated adrenocorticotropic hormone deficiency caused by nivolumab: a case report.
    Takeno A; Yamamoto M; Morita M; Tanaka S; Kanazawa I; Yamauchi M; Kaneko S; Sugimoto T
    BMC Endocr Disord; 2019 Feb; 19(1):25. PubMed ID: 30782163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic Scleroderma Induced by Nivolumab in Malignant Melanoma.
    Loupret T; Boisseau R; Lopez JG; Bertin P; Vergne-Salle P
    In Vivo; 2024; 38(3):1451-1453. PubMed ID: 38688588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nivolumab (OPDIVOO) BRAF V600 mutation-negative metastatic or inoperable melanoma: survival advantage.
    Prescrire Int; 2016 Dec; 25(177):289-292. PubMed ID: 30758924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complete ophthalmoplegia in Ipilmumab and Nivolumab combination treatment for metastatic melanoma.
    Alnabulsi R; Hussain A; DeAngelis D
    Orbit; 2018 Oct; 37(5):381-384. PubMed ID: 29381409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A rare case of eosinophilic gastritis induced by nivolumab therapy for metastatic melanoma.
    Tsuji A; Hiramatsu K; Namikawa S; Yamamoto A; Midori Y; Murata Y; Tanaka T; Nosaka T; Naito T; Takahashi K; Ofuji K; Matsuda H; Ohtani M; Imamura Y; Iino S; Hasegawa M; Nakamoto Y
    Clin J Gastroenterol; 2022 Oct; 15(5):876-880. PubMed ID: 35978213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune checkpoint inhibitor (nivolumab)-associated kidney injury and the importance of recognizing concomitant medications known to cause acute tubulointerstitial nephritis: a case report.
    Koda R; Watanabe H; Tsuchida M; Iino N; Suzuki K; Hasegawa G; Imai N; Narita I
    BMC Nephrol; 2018 Feb; 19(1):48. PubMed ID: 29486725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myasthenia Gravis Induced by Immune Checkpoint Inhibitors.
    Becquart O; Lacotte J; Malissart P; Nadal J; Lesage C; Guillot B; Du Thanh A
    J Immunother; 2019 Oct; 42(8):309-312. PubMed ID: 31246640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination therapy of ipilimumab and nivolumab induced thyroid storm in a patient with Hashimoto's disease and diabetes mellitus: a case report.
    Yonezaki K; Kobayashi T; Imachi H; Yoshimoto T; Kikuchi F; Fukunaga K; Sato S; Ibata T; Yamaji N; Lyu J; Dong T; Murao K
    J Med Case Rep; 2018 Jun; 12(1):171. PubMed ID: 29914537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late-onset hypophysitis after discontinuation of nivolumab treatment for advanced skin melanoma: a case report.
    Antoniou S; Bazazo G; Röckl L; Papadakis M; Berg C
    BMC Endocr Disord; 2021 Sep; 21(1):191. PubMed ID: 34544399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nivolumab Induces Sustained Liver Injury in a Patient with Malignant Melanoma.
    Matsubara T; Nishida T; Higaki Y; Tomita R; Shimakoshi H; Shimoda A; Osugi N; Sugimoto A; Takahashi K; Nakamatsu D; Mukai K; Yamamoto M; Fukui K; Adachi S; Inada M
    Intern Med; 2018 Jun; 57(12):1789-1792. PubMed ID: 29434164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 study.
    Long GV; Atkinson V; Lo S; Sandhu S; Guminski AD; Brown MP; Wilmott JS; Edwards J; Gonzalez M; Scolyer RA; Menzies AM; McArthur GA
    Lancet Oncol; 2018 May; 19(5):672-681. PubMed ID: 29602646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.